Key stats
Fund info
Home page
Inception date
Jan 17, 2017
Structure
Canadian Mutual Fund Trust (ON)
Dividend treatment
Distributes
Income tax type
Capital Gains
Primary advisor
Harvest Portfolios Group, Inc.
ISIN
CA41755F2061
CUSIP
41755F206
FIGI
BBG00FY97387
Identifiers
ISIN CA41755F2061
The fund actively managed portfolio starts with its investable universe, which consists of developed market healthcare companies whose market capitalization is at least $5 billion USD at the time of investment, and who meet the fund providers proprietary investment characteristics. The fund then equally weights the top 20 companies the adviser perceives as Healthcare Leaders from the universe. Quantitative factors such as yield, earnings per share growth, implied volatility and option liquidity are also considered when composing the portfolio. HHL aims to achieve (i) an average P/E ratio lower than the average of the investable universe, and (iii) an average 5-year ROE growth greater than the average of the universe. The fund also writes covered call options on up to 33% of the portfolio holdings to decrease volatility. Fund reconstitution and rebalancing is done quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks98.89%
Health Technology88.53%
Health Services9.88%
Bonds, Cash & Other1.11%
Cash1.17%
ETF0.43%
Miscellaneous0.27%
Rights & Warrants−0.76%
Breakdown by region
North America85.22%
Europe14.78%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently asked questions
HHL.U invests in stocks. The fund's major sectors are Health Technology, with 88.96% stocks, and Health Services, with 9.93% of the basket. The assets are mostly located in the North America region.
HHL.U top holdings are Regeneron Pharmaceuticals, Inc. and Boston Scientific Corporation, occupying 5.34% and 5.14% of the portfolio correspondingly.
HHL.U last dividends amounted to 0.06 USD. The month before, the issuer paid 0.06 USD in dividends,
HHL.U assets under management is 118.44 M USD. It's risen 12.64% over the last month.
HHL.U fund flows account for 5.72 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
HHL.U shares are issued by Harvest Portfolios Group, Inc. under the brand Harvest ETFs. The ETF was launched on Jan 17, 2017, and its management style is Active.
HHL.U expense ratio is 1.04% meaning you'd have to pay 1.04% of your investment to help manage the fund.
HHL.U follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
HHL.U invests in stocks.
HHL.U price has risen by 10.38% over the last month, and its yearly performance shows a 7.36% increase. See more dynamics on HHL.U price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 7.75% over the last month, showed a 13.38% increase in three-month performance and has increased by 16.64% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 7.75% over the last month, showed a 13.38% increase in three-month performance and has increased by 16.64% in a year.
HHL.U trades at a premium (0.50%) meaning the ETF is trading at a higher price than the calculated NAV.